{"id":843,"date":"2025-02-14T15:21:52","date_gmt":"2025-02-14T14:21:52","guid":{"rendered":"https:\/\/www.dsmtech.it\/prodotti\/age-reader\/"},"modified":"2025-11-05T15:00:02","modified_gmt":"2025-11-05T14:00:02","slug":"age-reader","status":"publish","type":"prodotti","link":"https:\/\/www.dsmtech.it\/en\/products\/age-reader\/","title":{"rendered":"AGE Reader"},"content":{"rendered":"\n\n\n\n
\n \n
\"\"<\/figure>\n \n
\n
\n
\n
\n \n
AGEs Analysis<\/div>\n

Non-invasive assessment of cardiovascular risk<\/h2>\n

The AGE Reader<\/strong> is an innovative, non-invasive medical device<\/strong> designed to assess cardiovascular risk<\/strong> through the measurement of Advanced Glycation End Products (AGEs)<\/strong> at the skin level.
Its non-invasiveness and ease of use make it perfectly suited for modern early-diagnosis and preventive <\/strong>medicine programs.<\/p>\n

By quantifying AGEs, the AGE Reader is particularly useful in the management of patients with diabetes, kidney disease, and other conditions associated with increased cardiovascular risk<\/strong>.<\/p>\n<\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n \n<\/section>\n\n\n\n\n\n\n\n\n

\n \n \n
\n \n

Measurement Principle<\/h2>\n

The AGE Reader operates by detecting the autofluorescence<\/strong> of AGEs in the skin.<\/p>\n

To perform a measurement, the patient simply places the inner forearm on the device, ensuring full contact with the measurement window.
The device emits ultraviolet light that induces tissue autofluorescence, directly correlated with AGE concentration in the skin.<\/p>\n

The examination takes only 12 seconds<\/strong>, and results are displayed immediately, allowing for real-time assessment of cardiovascular risk alongside other clinical parameters.<\/p>\n<\/div>\n <\/div>\n \n<\/section>\n\n\n\n\n\n\n\n\n

\n \n \n
\n \n

Clinical Applications<\/h2>\n

The AGE Reader<\/strong> can be applied in multiple clinical and preventive contexts:<\/p>\n